José Castillo, PhD Univercells

Jose’s has a background in Chemical Engineering, a PhD in Applied Sciences from Brussels University and an entrepreneurship degree from Solvay Business School (Belgium).

José was Head of Viral Vaccine Industrialization at GSK Vaccines. Founder of Artelis start-up, he designed and developed bioreactors that transformed industrial operations – the iCellis system being now considered as standard in the vaccines and gene therapy industry. The technology was industrialized at ATMI LifeSciences and Pall Lifesciences, where José was Cell Culture Technologies Director.

Currently, he is co-founder and CTO of Univercells, a Belgian company with the mission of increasing the availability of affordable vaccines and biotherapeutics to address global health challenges. The company develops turnkey solutions by relying on proprietary core technologies and a continuous process intensification approach, achieving production with a smaller footprint, and significantly lower overall capital and operational costs.